Can anyone tell me what they are currently doing as far as labeling IHC
(for clinical use) as ASR.  The antibodies I am using are not coming
from the manufacturer labeled as ASR.  Am I wrong not to include the ASR
statement as part of the report?
 
Pat Zeitlow
Molecular Pathology Manager
Boyce and Bynum Laboratories
573-886-4688